
	Three Months Ended April 30,				Nine Months Ended April 30,
	2026		2025		2026		2025

	(in thousands, except per share data)
Net loss	$	(13,883)	$	(4,125)	$	(59,810)	$	(23,900)
Weighted-average shares used in computing net loss per share, basic and diluted	160,741		154,909		159,662		153,699
Net loss per share, basic and diluted	$	(0.09)	$	(0.03)	$	(0.37)	$	(0.16)

Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share as their effect is antidilutive and accordingly, the basic and diluted net loss per share is the same for all periods presented.

We calculate the potential dilutive effect of the convertible senior notes under the if-converted method. Under this method, diluted earnings per share are determined by assuming that outstanding convertible senior notes were converted into shares of our common stock at the beginning of the reporting period. In connection with the issuance of the convertible senior notes, we entered into the capped call transactions, which were not included for purposes of calculating the number of diluted

shares outstanding, as their effect would have been anti-dilutive. The capped call transactions are expected to partially offset the potential dilution to our common stock upon any conversion of the convertible senior notes.

The following table summarizes the outstanding potentially dilutive securities that were excluded from the computation of diluted net loss per share as their effect would be antidilutive:


	April 30,
	2026	2025

	(in thousands)
Unvested RSUs and shares of common stock	9,089	9,498
Unvested PSAs (1)	1,002	1,072
Share purchase rights under the ESPP	717	926
Stock options	150	171
2028 Notes (2)	3,925	—
2025 Notes (2)	—	7,626
Total	14,883	19,293

(1) The number of unvested PSAs is estimated at 100% of the target number of shares granted and excludes unvested PSAs for which performance conditions have not been established as of April 30, 2026 and 2025, as they are not considered outstanding for accounting purposes. For further information refer to Note 13, Stock-Based Compensation.